Literature DB >> 21227490

Financing health care for all: challenges and opportunities.

A K Shiva Kumar1, Lincoln C Chen, Mita Choudhury, Shiban Ganju, Vijay Mahajan, Amarjeet Sinha, Abhijit Sen.   

Abstract

India's health financing system is a cause of and an exacerbating factor in the challenges of health inequity, inadequate availability and reach, unequal access, and poor-quality and costly health-care services. Low per person spending on health and insufficient public expenditure result in one of the highest proportions of private out-of-pocket expenses in the world. Citizens receive low value for money in the public and the private sectors. Financial protection against medical expenditures is far from universal with only 10% of the population having medical insurance. The Government of India has made a commitment to increase public spending on health from less than 1% to 3% of the gross domestic product during the next few years. Increased public funding combined with flexibility of financial transfers from centre to state can greatly improve the performance of state-operated public systems. Enhanced public spending can be used to introduce universal medical insurance that can help to substantially reduce the burden of private out-of-pocket expenditures on health. Increased public spending can also contribute to quality assurance in the public and private sectors through effective regulation and oversight. In addition to an increase in public expenditures on health, the Government of India will, however, need to introduce specific methods to contain costs, improve the efficiency of spending, increase accountability, and monitor the effect of expenditures on health.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21227490     DOI: 10.1016/S0140-6736(10)61884-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  Variations in catastrophic health expenditure estimates from household surveys in India.

Authors:  Magdalena Z Raban; Rakhi Dandona; Lalit Dandona
Journal:  Bull World Health Organ       Date:  2013-07-12       Impact factor: 9.408

Review 2.  Towards achievement of universal health care in India by 2020: a call to action.

Authors:  K Srinath Reddy; Vikram Patel; Prabhat Jha; Vinod K Paul; A K Shiva Kumar; Lalit Dandona
Journal:  Lancet       Date:  2011-01-10       Impact factor: 79.321

3.  Burden of healthcare utilization and out-of-pocket costs among individuals with NCDs in an Indian setting.

Authors:  Ashish Joshi; Krishna Mohan; Gurmit Grin; Douglas Marcel Puricelli Perin
Journal:  J Community Health       Date:  2013-04

4.  Public expenditure and healthcare utilization: the case of reproductive health care in India.

Authors:  Dhiman Das
Journal:  Int J Health Econ Manag       Date:  2017-07-12

Review 5.  Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries.

Authors:  Sumanth Gandra; Gerardo Alvarez-Uria; Paul Turner; Jyoti Joshi; Direk Limmathurotsakul; H Rogier van Doorn
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

6.  Universal health care in India: the time is right.

Authors:  Vikram Patel; A K Shiva Kumar; Vinod K Paul; Krishna D Rao; K Srinath Reddy
Journal:  Lancet       Date:  2011-01-10       Impact factor: 79.321

7.  TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis.

Authors:  Aswin M Nair; P Sandhya; Bijesh Yadav; Debashish Danda
Journal:  Clin Rheumatol       Date:  2017-06-23       Impact factor: 2.980

8.  Survival analysis of Down syndrome cohort in a tertiary health care center in India.

Authors:  Risha Nahar; Udhaya Kotecha; Ratna Dua Puri; Ravindra Mohan Pandey; Ishwar Chander Verma
Journal:  Indian J Pediatr       Date:  2012-07-26       Impact factor: 1.967

9.  Three-year data from the XIENCE V INDIA study: safety and efficacy of XIENCE V in 1000 real world Indian patients.

Authors:  Ashok Seth; Tejas M Patel; Marrianne Stuteville; Ravindra Kumar; Ajit S Mullasari; Upendra Kaul; Rony Mathew; A Sreenivas Kumar; Shih-Wa Ying; Krishnankutty Sudhir
Journal:  Indian Heart J       Date:  2014-04-18

10.  Study of Drug Utilization Pattern for Skin Diseases in Dermatology OPD of an Indian Tertiary Care Hospital - A Prescription Survey.

Authors:  Anuj Kumar Pathak; Subodh Kumar; Manish Kumar; Lalit Mohan; Harihar Dikshit
Journal:  J Clin Diagn Res       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.